Page last updated: 2024-11-04

sibutramine and Inappropriate ADH Syndrome

sibutramine has been researched along with Inappropriate ADH Syndrome in 1 studies

sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride

Inappropriate ADH Syndrome: A condition of HYPONATREMIA and renal salt loss attributed to overexpansion of BODY FLUIDS resulting from sustained release of ANTIDIURETIC HORMONES which stimulates renal resorption of water. It is characterized by normal KIDNEY function, high urine OSMOLALITY, low serum osmolality, and neurological dysfunction. Etiologies include ADH-producing neoplasms, injuries or diseases involving the HYPOTHALAMUS, the PITUITARY GLAND, and the LUNG. This syndrome can also be drug-induced.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Esposito, P1
Rampino, T1
Gregorini, M1
Soccio, G1
Piotti, G1
Bedino, G1
Balenzano, CT1
Roscini, E1
Cosmai, L1
Portalupi, V1
Libetta, C1
Dal Canton, A1

Other Studies

1 other study available for sibutramine and Inappropriate ADH Syndrome

ArticleYear
Severe symptomatic hyponatremia during sibutramine therapy: a case report.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2008, Volume: 52, Issue:1

    Topics: Appetite Depressants; Body Mass Index; Cyclobutanes; Diagnosis, Differential; Emergency Service, Hos

2008